Press Releases BIOLASE, Inc.

Equities

BIOL

US0909117022

Delayed Nasdaq Other stock markets 12:02:53 2024-04-29 pm EDT			5-day change	1st Jan Change
0.1451 ^USD	-1.96%		-3.27%	-87.07%

Apr. 01	Ascendiant Capital Adjusts Biolase's Price Target to $4 From $15, Reiterates Buy Rating	MT
Mar. 22	Wall Street Set to Open Marginally Lower Friday Following Powell Speech, After Hitting Record Highs Thursday	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Biolase: Q4 Earnings Snapshot	Mar. 21	AQ
BIOLASE TO REPORT FOURTH QUARTER AND FULL YEAR 2023 RESULTS ON MARCH 21, 2024	Mar. 15	AQ
BIOLASE LAUNCHES STATE-OF-THE-ART ALL-TISSUE LASER SYSTEM TO ACCELERATE ADOPTION OF LASERS IN DENTISTRY	Feb. 23	AQ
BIOLASE ANNOUNCES FIRST QUARTER 2024 WEBINAR SERIES 'LETS TALK DENTAL'	Feb. 21	AQ
BIOLASE, INC. GRANTED EXTENSION BY NASDAQ TO REGAIN COMPLIANCE WITH THE STOCKHOLDERS EQUITY CONTINUED LISTING REQUIREMENT	Feb. 15	AQ
BIOLASE REPORTS UNAUDITED REVENUE GROWTH FOR FULL YEAR 2023 AND PROVIDES OUTLOOK FOR FULL YEAR 2024	Jan. 30	AQ
BIOLASE, Inc. Announces Pricing of $1.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	Dec. 06	PR
Biolase: Q3 Earnings Snapshot	Nov. 09	AQ
BIOLASE REPORTS THIRD QUARTER FINANCIAL RESULTS; COMPANY BENEFITTING FROM STRATEGIC ACTIONS TAKEN TO STREAMLINE OPERATIONS AND GAIN GREATER OPERATIONAL EFFICIENCIES	Nov. 09	PR
LANDMARK STUDY PERFORMED BY THE INDEPENDENT MCGUIRE INSTITUTE CONFIRMS POSITIVE 12 MONTH CLINICAL OUTCOMES FOR BIOLASE REPAIR PERIO PROTOCOL	Nov. 09	AQ
BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants	23-09-18	PR
BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants	23-09-13	PR
Biolase: Q2 Earnings Snapshot	23-08-10	AQ
Four Dynamic Stocks and their Latest Moves (CAVR, IDEX, NAVB, BIOL)	23-07-13	AQ
BIOLASE, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	23-06-13	AQ
BIOLASE ANNOUNCES DISTRIBUTION OF SERIES I PREFERRED STOCK TO HOLDERS OF ITS COMMON STOCK	23-06-05	PR
BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants	23-05-26	PR
BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants	23-05-24	PR
Biolase: Q1 Earnings Snapshot	23-05-11	AQ
BIOLASE : Submission of Matters to a Vote of Security Holders - Form 8-K	23-05-03	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases BIOLASE, Inc.

Equities

BIOL

US0909117022

Press Releases

Filters